Feasibility and outcome of automated kinetic perimetry in children.

Peripheral Visual Fields in Children and Young Adults Using Semi-automated Kinetic Perimetry: Feasibility of Testing, Normative Data, and Repeatability. Neuroophthalmology (2014) 0.81

Study of Optimal Perimetric Testing in Children (OPTIC): Feasibility, Reliability and Repeatability of Perimetry in Children. PLoS One (2015) 0.80

Development of a Pediatric Visual Field Test. Transl Vis Sci Technol (2016) 0.77

Evaluation of kinetic programs in various automated perimeters. Jpn J Ophthalmol (2017) 0.75

Normal Threshold Size of Stimuli in Children Using a Game-Based Visual Field Test. Ophthalmol Ther (2016) 0.75

Visual fields at school-age in children treated with vigabatrin in infancy. Epilepsia (2009) 2.92

The reliability of frequency-doubling perimetry in young children. Ophthalmology (2004) 1.47

Feasibility of automated visual field examination in children between 5 and 8 years of age. Br J Ophthalmol (1996) 1.44

Visual fields in 4- to 10-year-old children using Goldmann and double-arc perimeters. J Pediatr Ophthalmol Strabismus (1992) 1.30

Comparison between semiautomated kinetic perimetry and conventional Goldmann manual kinetic perimetry in advanced visual field loss. Ophthalmology (2005) 1.13

Distance and near visual acuity, contrast sensitivity, and visual fields of 10-year-old children. Arch Ophthalmol (1999) 1.08

The use of semi-automated kinetic perimetry (SKP) to monitor advanced glaucomatous visual field loss. Graefes Arch Clin Exp Ophthalmol (2008) 0.90

Does visual sensitivity improve between 5 and 8 years? A study of automated visual field examination. Vision Res (1999) 0.88

The feasibility of short automated static perimetry in children. Ophthalmology (2001) 0.87

Automated visual field examination in children aged 5-8 years. Part II: Normative values. Vision Res (1998) 0.87

Visual field constriction in 91 Finnish children treated with vigabatrin. Epilepsia (2002) 0.87

Peripheral and central visual fields in 11-year-old children who had been born prematurely and at term. J Pediatr Ophthalmol Strabismus (2004) 0.86

Visual fields of infants assessed with a new perimetric technique. Invest Ophthalmol Vis Sci (1988) 0.86

Normative values for visual fields in 4- to 12-year-old children using kinetic perimetry. J Pediatr Ophthalmol Strabismus (1991) 0.86

Assessment of an effective visual field testing strategy for a normal pediatric population. Ophthalmologica (2008) 0.86

Feasibility and outcome of automated static perimetry in children using continuous light increment perimetry (CLIP) and fast threshold strategy. Acta Ophthalmol Scand (2005) 0.85

Binocular visual field changes after surgery in esotropic amblyopia. Invest Ophthalmol Vis Sci (2004) 0.82

Static perimetry in young children. Vision Res (1969) 0.80

Automated visual field examination in children aged 5-8 years. Part I: Experimental validation of a testing procedure. Vision Res (1998) 0.80

Frequency doubling technology threshold testing in the pediatric age group. J Glaucoma (2004) 0.80

Visual field defects in children with congenital glaucoma. J Pediatr Ophthalmol Strabismus (2001) 0.79

[Automated kinetic perimetry using different stimulus velocities]. Ophthalmologe (2001) 0.78

Late visual field changes following cryotherapy for retinopathy of prematurity stage 3. Br J Ophthalmol (1995) 0.78

Constriction of the visual field of children after early visual deprivation. J Pediatr Ophthalmol Strabismus (1998) 0.78

HPR perimetry and Humphrey perimetry in glaucomatous children. Doc Ophthalmol (1995) 0.77

[The quantitative visual field of children (author's transl)]. Nippon Ganka Gakkai Zasshi (1974) 0.75

[Kinetic and static perimetries in young children (author's transl)]. Nippon Ganka Gakkai Zasshi (1973) 0.75

Kinetic perimetry in neuroophthalmological practice. Strabismus (2000) 0.75

Long-term visual results following primary trabeculectomy for infantile glaucoma. Acta Ophthalmol Scand (2001) 0.75

Human TUBB3 mutations perturb microtubule dynamics, kinesin interactions, and axon guidance. Cell (2010) 4.37

CNGB3 mutations account for 50% of all cases with autosomal recessive achromatopsia. Eur J Hum Genet (2005) 2.37

Heterozygous mutations of OTX2 cause severe ocular malformations. Am J Hum Genet (2005) 2.26

SOX2 anophthalmia syndrome. Am J Med Genet A (2005) 2.24

Genotyping microarray (disease chip) for Leber congenital amaurosis: detection of modifier alleles. Invest Ophthalmol Vis Sci (2005) 2.20

BIGH3 mutation spectrum in corneal dystrophies. Invest Ophthalmol Vis Sci (2002) 2.19

Mutations in the cone photoreceptor G-protein alpha-subunit gene GNAT2 in patients with achromatopsia. Am J Hum Genet (2002) 2.10

TRPM1 is mutated in patients with autosomal-recessive complete congenital stationary night blindness. Am J Hum Genet (2009) 1.93

FOXL2 and BPES: mutational hotspots, phenotypic variability, and revision of the genotype-phenotype correlation. Am J Hum Genet (2003) 1.70

Increasing the yield in targeted next-generation sequencing by implicating CNV analysis, non-coding exons and the overall variant load: the example of retinal dystrophies. PLoS One (2013) 1.40

Lack of fundus autofluorescence to 488 nanometers from childhood on in patients with early-onset severe retinal dystrophy associated with mutations in RPE65. Ophthalmology (2004) 1.39

Novel mutations in FRMD7 in X-linked congenital nystagmus. Mutation in brief #963. Online. Hum Mutat (2007) 1.38

Disease-causing 7.4 kb cis-regulatory deletion disrupting conserved non-coding sequences and their interaction with the FOXL2 promotor: implications for mutation screening. PLoS Genet (2009) 1.32

Phenotypes of 16 Stargardt macular dystrophy/fundus flavimaculatus patients with known ABCA4 mutations and evaluation of genotype-phenotype correlation. Graefes Arch Clin Exp Ophthalmol (2002) 1.26

X-linked retinitis pigmentosa: RPGR mutations in most families with definite X linkage and clustering of mutations in a short sequence stretch of exon ORF15. Invest Ophthalmol Vis Sci (2003) 1.25

Identification and in vitro expression of novel CDH23 mutations of patients with Usher syndrome type 1D. Hum Mutat (2002) 1.25

Whole-exome sequencing identifies mutations in GPR179 leading to autosomal-recessive complete congenital stationary night blindness. Am J Hum Genet (2012) 1.25

Congenital cataract and macular hypoplasia in humans associated with a de novo mutation in CRYAA and compound heterozygous mutations in P. Graefes Arch Clin Exp Ophthalmol (2006) 1.23

Role of SOX2 mutations in human hippocampal malformations and epilepsy. Epilepsia (2006) 1.22

Detection of intact rAAV particles up to 6 years after successful gene transfer in the retina of dogs and primates. Mol Ther (2008) 1.20

Fundus autofluorescence in children and teenagers with hereditary retinal diseases. Graefes Arch Clin Exp Ophthalmol (2005) 1.19

Oculo-auriculo-vertebral spectrum (OAVS): clinical evaluation and severity scoring of 53 patients and proposal for a new classification. Eur J Med Genet (2005) 1.15

Genotyping microarray for CSNB-associated genes. Invest Ophthalmol Vis Sci (2009) 1.10

Large deletions of the KCNV2 gene are common in patients with cone dystrophy with supernormal rod response. Hum Mutat (2011) 1.06

Identification of novel mutations in X-linked retinitis pigmentosa families and implications for diagnostic testing. Mol Vis (2008) 1.05

Gene therapy for vision loss -- recent developments. Discov Med (2010) 1.04

Thirty distinct CACNA1F mutations in 33 families with incomplete type of XLCSNB and Cacna1f expression profiling in mouse retina. Eur J Hum Genet (2002) 1.03

Fundus autofluorescence in carriers of X-linked recessive retinitis pigmentosa associated with mutations in RPGR, and correlation with electrophysiological and psychophysical data. Graefes Arch Clin Exp Ophthalmol (2004) 1.01

Screening of TYR, OCA2, GPR143, and MC1R in patients with congenital nystagmus, macular hypoplasia, and fundus hypopigmentation indicating albinism. Mol Vis (2011) 1.00

Fourteen novel OPA1 mutations in autosomal dominant optic atrophy including two de novo mutations in sporadic optic atrophy. Hum Mutat (2003) 0.99

Longitudinal and cross-sectional study of patients with early-onset severe retinal dystrophy associated with RPE65 mutations. Graefes Arch Clin Exp Ophthalmol (2004) 0.98

Bilateral tonic pupils with evidence of anti-hu antibodies as a paraneoplastic manifestation of small cell lung cancer. Ophthalmologica (2004) 0.97

Functional antibodies targeting IsaA of Staphylococcus aureus augment host immune response and open new perspectives for antibacterial therapy. Antimicrob Agents Chemother (2010) 0.96

Phenotypic variability in three carriers from a family with choroideremia and a frameshift mutation 1388delCCinsG in the REP-1 gene. Ophthalmic Genet (2003) 0.96

Novel causative mutations in patients with Nance-Horan syndrome and altered localization of the mutant NHS-A protein isoform. Mol Vis (2008) 0.92

Misrouting of the optic nerves in albinism: estimation of the extent with visual evoked potentials. Invest Ophthalmol Vis Sci (2005) 0.91

Unilateral adult malignant optic nerve glioma. Graefes Arch Clin Exp Ophthalmol (2004) 0.91

Fundus autofluorescence in carriers of choroideremia and correlation with electrophysiologic and psychophysical data. Ophthalmology (2009) 0.90

Disturbed visual system function in methionine synthase deficiency. Graefes Arch Clin Exp Ophthalmol (2004) 0.90

Superior oblique tucking with versus without additional inferior oblique recession for acquired trochlear nerve palsy. Graefes Arch Clin Exp Ophthalmol (2009) 0.89

Automated segmentation of pathological cavities in optical coherence tomography scans. Invest Ophthalmol Vis Sci (2013) 0.89

Fundus albipunctatus associated with compound heterozygous mutations in RPE65. Ophthalmology (2011) 0.89

Pediatric clinical visual electrophysiology: a survey of actual practice. Doc Ophthalmol (2006) 0.88

RPGR: role in the photoreceptor cilium, human retinal disease, and gene therapy. Ophthalmic Genet (2010) 0.88

Lack of autofluorescence in fundus albipunctatus associated with mutations in RDH5. Retina (2010) 0.88

Automated segmentation of retinal blood vessels in spectral domain optical coherence tomography scans. Biomed Opt Express (2012) 0.87

Mosaic synaptopathy and functional defects in Cav1.4 heterozygous mice and human carriers of CSNB2. Hum Mol Genet (2013) 0.84

Mutation analysis in a family with oculocutaneous albinism manifesting in the same generation of three branches. Mol Vis (2007) 0.84

Comparison of central retinal thickness in healthy children and adults measured with the Heidelberg Spectralis OCT and the zeiss Stratus OCT 3. Ophthalmologica (2010) 0.84

Bestrophin 1--Phenotypes and Functional Aspects in Bestrophinopathies. Ophthalmic Genet (2015) 0.83

[On the effect of mutations of the fibroblast growth factor receptors as exemplified by three cases of craniosynostoses]. Klin Monbl Augenheilkd (2003) 0.83

Mutations in RD3 are associated with an extremely rare and severe form of early onset retinal dystrophy. Invest Ophthalmol Vis Sci (2012) 0.83

In vivo assessment of retinal vascular wall dimensions. Invest Ophthalmol Vis Sci (2010) 0.82

Long-term follow-up of the human phenotype in three siblings with cone dystrophy associated with a homozygous p.G461R mutation of KCNV2. Invest Ophthalmol Vis Sci (2011) 0.82

Evolution of central corneal thickness in children with congenital glaucoma requiring glaucoma surgery. Graefes Arch Clin Exp Ophthalmol (2007) 0.82

Impaired sleep quality and restless legs syndrome in idiopathic focal dystonia: a controlled study. J Neurol (2011) 0.81

OCT-Based Macular Structure-Function Correlation in Dependence on Birth Weight and Gestational Age-the Giessen Long-Term ROP Study. Invest Ophthalmol Vis Sci (2016) 0.80

Age matters--thoughts on a grading system for ABCA4 mutations. Graefes Arch Clin Exp Ophthalmol (2004) 0.80

Heritability of strabismus: genetic influence is specific to eso-deviation and independent of refractive error. Twin Res Hum Genet (2012) 0.80

Interchangeability of macular thickness measurements between different volumetric protocols of Spectralis optical coherence tomography in normal eyes. Graefes Arch Clin Exp Ophthalmol (2011) 0.79

Fundus-controlled two-color dark adaptometry with the Microperimeter MP1. Graefes Arch Clin Exp Ophthalmol (2015) 0.79

Evidence of intrafamilial variability of CBFA1/RUNX2 expression in cleidocranial dysplasia--a family study. J Orofac Orthop (2002) 0.79

De novo double mutation in PAX6 and mtDNA tRNA(Lys) associated with atypical aniridia and mitochondrial disease. J Mol Med (Berl) (2006) 0.79

The effects of midazolam on intraocular pressure in children during examination under sedation. Br J Ophthalmol (2010) 0.79

Analysis of three genes in Leber congenital amaurosis in Indonesian patients. Vision Res (2003) 0.78

Electron microscopic findings in levator muscle biopsies of patients with isolated congenital or acquired ptosis. Graefes Arch Clin Exp Ophthalmol (2007) 0.78

Improving detection of mild loss of retinal light increment sensitivity at the posterior pole with the microperimeter MP1. Invest Ophthalmol Vis Sci (2013) 0.77

Prevalence and diagnostic spectrum of generalized retinal dystrophy in Danish children. Ophthalmic Epidemiol (2013) 0.76

Assessment of cortical visual field representations with multifocal VEPs in control subjects, patients with albinism, and female carriers of ocular albinism. Invest Ophthalmol Vis Sci (2006) 0.76

Normative values of peripheral retinal thickness measured with Spectralis OCT in healthy young adults. Graefes Arch Clin Exp Ophthalmol (2014) 0.75

Systematic review of digital imaging screening strategies for retinopathy of prematurity. Pediatrics (2009) 0.75

The Brückner transillumination test: limited detection of small-angle esotropia. Ophthalmology (2011) 0.75

Two patients with the heterozygous R189H mutation in ACTA2 and Complex congenital heart defects expands the cardiac phenotype of multisystemic smooth muscle dysfunction syndrome. Am J Med Genet A (2017) 0.75

Shared decision-making, control preferences and psychological well-being in patients with RPE65 deficiency awaiting experimental gene therapy. Ophthalmic Res (2015) 0.75

In search for increased prevalence rates of strabismus and microstrabismus in two Bavarian districts, Oberpfalz and Niederbayern, to spot populations for gene identification. Strabismus (2002) 0.75